CW ANALYTICAL EXPANDS OFFERINGS WITH ORANGE PHOTONICS PARTNERSHIP

Oakland, CA: CW Analytical Laboratories Inc, a leading laboratory in California’s Cannabis industry, and Orange Photonics Inc, producer of portable Cannabinoid analyzers, are pleased to announce their distribution partnership throughout the state of California.

Utilizing a modified version of the same high pressure liquid chromatography currently used to measure cannabinoid content in a laboratory setting, LightLab™ allows users to evaluate the potency of flowers and extracts from the location of their choosing.

“We’re thrilled to finally evaluate a portable analytical machine that measures analytes based upon a reference standard rather than a reference database currently used by portable infrared technologies,” says Dr. Robert Martin, CEO of CW Analytical. “This new machine has passed all of our testing trials with flying colors and is both reliable and affordable. We look forward to creating a new company to offer sales and user support for this exciting technology.”

While alternative options for on-demand potency testing usually lack affordability, reliability, and consistency, LightLab™ stands alone as the ideal solution for expanding CW Analytical’s already expansive potency and quality assurance testing options.

“Turnaround time is a huge pain point for our clients,” says Emily Richardson, Vice President of Business Development at CW Analytical. “Whether it’s an extractor making a purchasing decision on trim, or a grower refining a breeding program, LightLab™ offers an accurate and affordable way to measure Cannabinoid content on-site, without the time and logistics involved with getting a sample to our lab.”

“We are pleased to work with CW Analytical. Their commitment to analytical excellence and exceptional customer service makes them a natural partner for Orange Photonics.” says Stephanie McArdle, President of Orange Photonics. “Our customers will benefit from CW’s deep understanding of cannabis business operations and the opportunity to boost efficiency by integrating real-time quality control data from LightLab™.”

 

About CW Analytical Laboratories Inc:

A pioneer in Cannabis science, CW Analytical was one of the first laboratories of its kind to serve the Cannabis industry. The company was co-founded in 2009 by two scientists who noticed that the medical Cannabis industry in California was lacking the regulatory and quality assurance practices necessary to ensure the availability of clean, safe medicine. CW Analytical's team of scientists and industry experts has been providing stakeholders in California with important information about the safety, quality, and potency of medical Cannabis products long before any state mandate.

CW Analytical’s commitment to continuous innovation and technical development has led to the achievement of ISO 17025 accreditation, collaborative research, and the procurement of state-of-the-art analytical instruments to keep CW and their clients at the forefront of regulatory compliance.

CW Analytical's continued success is due to our commitment to providing clients with accurate, affordable data paired with unrivaled customer service. The company's mission is to enable clients to better serve their patients and compete in the medical Cannabis marketplace with the safest, cleanest, and most consistent medicine in California.

 

About Orange Photonics Inc.:

Orange Photonics, Inc. provides portable, onsite Cannabis potency analysis for growers, retailers and regulators. LightLab™, Orange Photonics’ flagship product, is a portable Cannabis analyzer that provides accurate potency data in under 10 minutes. The patent pending combination of liquid chromatography and spectroscopy includes technology used on NASA’s Curiosity Mars rover. LightLab™ offers easy access to real-time potency data which means cultivators and concentrate producers can quickly modify manufacturing processes, fine-tune cultivation inputs, immediately value raw materials in their supply chain, and produce consistent, optimized end product.

 

Come Inside CW Analytical at the NCIA Cannabiz Conference June 12th, 2017!

We're excited to announce that for the second year in a row, we will be offering tours of our laboratory to NCIA conference attendees at 10:30am, 1:00pm and 3:30pm on Monday June 12th, 2017. While the first two tours are already sold out, there are still sign-ups available for the 3:30 tour. If you're interested in seeing some of the upgrades and fancy new pieces of equipment we've got in-house, get on the list! We'll also have an Orange Photonics LightLab (portable Cannabis potency testing device) set-up for viewing. We'll be announcing an exciting partnership with Orange Photonics in the coming days.  

Click here to read more about our tour

 

 

Draft Regulations Released for Cannabis Cultivation and Manufacturing on April 28th, 2017

The California Department of Public Health, The California Department of Food and Agriculture, and the Bureau of Medical Cannabis Regulation today released proposed regulations for their respective areas of oversight - Cannabis Cultivation, Cannabis Manufacturing, and for the BMCR's document - all Cannabis licensees. The 45 day public comment period will end on June 13th. 

Click on the links below to read the full text of each document. 

Cannabis Manufacturing Proposed Regulations:

 http://www.cdph.ca.gov/services/DPOPP/regs/Documents/03DPH-17-004%20RegText%20Final%204.21.17%20LMC.pdf

Cultivation Proposed Regulations:

https://static.cdfa.ca.gov/MCCP/document/CalCannabis%20Proposed%20Medical%20Regulations_4.28.17.pdf

 

BMCR Proposed Regulations:

http://bmcr.ca.gov/laws_regs/mcrsa_ptor.pdf

CW Analytical Laboratories Announces Validated Method for Pesticide Screening on Cannabis

OAKLAND, Calif., March 1, 2017 /PRNewswire/ -- After months of method development and validation with SCIEX Corporation, CW Analytical (CWAL), an ISO 17025 accredited Cannabis testing laboratory, today announced they will be reporting up to 55 toxic chemical residues at parts-per-billion levels using triple quadrupole mass spectrometry technology. 

With this enhanced capability, CWAL will empower its clients to achieve regulatory compliance prior to the full implementation of the Medical Cannabis Regulation and Safety Act (MCRSA) and Adult Use of Marijuana Act (AUMA) in 2018. In addition, this technology will give those that test with CW Analytical the added confidence that they are providing the safest possible medicine to their patients. "This method allows us to detect these harmful compounds with unprecedented certainty and sensitivity," said David Egerton, Vice President of Technical Operations at CW Analytical. "As LC-MS/MS technology is a highly selective technique, previous instrument-based limitations regarding false positives can be considered a thing of the past."

While the use of pesticides in Cannabis cultivation is concerning and widespread, CW Analytical is committed to assisting those who are currently using these chemical compounds transition to organic methods. CWAL has also developed methods to aid concentrate and infused product producers in determining the cleanliness and safety of trim or flower prior to purchase using micro-extraction techniques.

Despite recent sensationalist reporting, Cannabis remains a safe alternative medicine that has been used successfully for thousands of years. The CWAL team is heartened by the dedication of the California Cannabis industry to evolve and produce safer, cleaner Cannabis than ever before, and serve as an example to producers of other agricultural products. 

2017 is an important transitionary time for the industry as the state of CA begins to release testing and other industry regulations. CWAL urges cultivators and producers to work with their preferred ISO accredited laboratory to make this transition smooth and compliance simple. "CW Analytical remains committed to the health of Cannabis consumers and the future success of California Cannabis businesses," said Robert Martin, Ph.D., CW Analytical Co-founder and COO. "Ultimately, this will ensure California's leadership role in the emerging global Cannabis industry." 

About CW Analytical

Founded in 2009 by a chemist and a microbiologist, CW Analytical's team of scientists and industry experts has been providing patients, cultivators, producers and dispensaries in California with important information about the safety, quality, and potency of their medical Cannabis products long before any state mandate.

The company's commitment to continuous innovation and technical development has led to strategic partnerships with companies like SCIEX and the achievement of ISO 17025 accreditation in August of 2016.

CW Analytical's continued success is due to its ability to provide clients with accurate data at an affordable price coupled with quick turnaround times and unrivaled customer service. The company's mission is to enable clients to better serve their patients and compete in the medical Cannabis marketplace with the safest, cleanest, and most consistent medicine in California. 

Simon Roberts P.hD, Field Application Specialist With SCIEX And David Egerton M.S., Vice President Of Technical Operations, Stand With "Sasquatch" CW Analytical's New LC-MS/MS (photo by kevin kerr)

Simon Roberts P.hD, Field Application Specialist With SCIEX And David Egerton M.S., Vice President Of Technical Operations, Stand With "Sasquatch" CW Analytical's New LC-MS/MS (photo by kevin kerr)

Dr. Robert Martin to speak at Pittcon 2017 - The World's Leading Annual Conference and Exposition on Laboratory Science

Pittcon 2017 will be held from March 5th-9th in Chicago, IL. Pittcon started as a small technical conference and exposition that was first held in the William Penn Hotel in Pittsburgh in February, 1950.

 

Pittcon is made up of the Spectroscopy Society of Pittsburgh (SSP) and the Society for Analytical Chemists of Pittsburgh (SACP).

This year is the first year Pittcon will incorporate Cannabis analysis and science, and our co-founder, Dr. Robert Martin, has been invited to speak on behalf of the Association of Commercial Cannabis Laboratories. 

"The symposium will also hear from Robert Martin, representing the Association of Commercial Cannabis Laboratories, who will outline their efforts to try to establish evidence-based quality measures for cannabis testing. The talk will touch upon issues faced in pesticides, residual solvents and microbiological testing, as well as consider the future of the cannabis testing industry."

Read the Pittcon Cannabis Testing Industry Guide Here